Why Equifax (EFX) stock is trading up today

Equifax, the prominent credit reporting agency, saw its stock price rise by 6.3% during the afternoon trading session, following an upgrade from Argus analyst John Eade. Eade raised his rating on Equifax's shares from Hold to Buy and established a price target of $200. He indicated that the company has moved beyond the challenges posed by its previous data breaches and is now on a steady growth trajectory, bolstered by a new consumer credit-scoring model that is gaining traction. Additionally, Eade noted a recent increase in dividends, which suggests that the company's management is more optimistic about its future cash flow.

According to Argus, Equifax's shares are currently valued at 17 times its projected earnings for 2027, which falls at the lower end of its historical valuation range, typically between 17 and 33 times earnings. This upgrade comes after Equifax's third-quarter performance, which showed adjusted earnings of $2.26 per share, surpassing the consensus estimate of $2.20. The company also reported a 9.6% increase in revenue, which reached $1.69 billion. However, concerns remain regarding weakness in mortgage volumes and a fourth-quarter outlook that does not meet Wall Street's expectations.

The fluctuations in Equifax's stock price have been notable, with the shares experiencing 13 movements of more than 5% over the past year. Today's increase suggests that investors view the news as significant, although it may not drastically alter the overall market perception of the company.

Just two days prior to this surge, Equifax's stock had increased by 5.6% after the company announced a 10% rise in revenue for the third quarter of 2026, totaling $1.693 billion. This growth was attributed to strong performance in its key business areas, with revenue increasing by 9% in local currency. The Diversified Markets segment saw an 8% rise, while the U.S. Information Solutions (USIS) division experienced a notable 13% growth. In a challenging market environment, U.S. mortgage revenue still managed to climb by 15%.

Equifax also highlighted its commitment to innovation, announcing that its new product, the Vitality Index—which tracks revenue generated from recently launched products—had achieved a record high of over 17%. Additionally, the company returned $158 million to its shareholders through share buybacks and quarterly dividends, a move that reflects strong operational performance and aims to reassure investors that the growth in its diverse data services can help mitigate ongoing challenges in the mortgage sector.

Despite the recent uptick, Equifax's stock is down 12.6% year-to-date. Currently, it is priced at $187.04 per share, which is 20% lower than its 52-week peak of $233.80 recorded in October 2025. Investors who purchased $1,000 worth of Equifax shares five years ago would now see their investment valued at approximately $697.18.

In other news, while Wall Street remains focused on various AI developments, there is a lesser-known AI application stock that is reportedly generating significant profits. This company processes a staggering trillion consumer signals each month using AI technology and is trading at only a fraction of the price compared to AI chip stocks, which are considered highly overvalued. Analysts suggest that this price discrepancy may not last long as institutional investors begin to recognize its potential. A free report detailing this opportunity is available for those interested in learning more.